MDisrupt, a leading health tech and life sciences marketplace, has announced a significant investment and strategic collaboration with American Heart Association Ventures. The $1 million investment, guided by milestones, marks a new chapter for MDisrupt as it expands its Artificial Intelligence-Powered Health Expert Marketplace. This innovative platform connects companies with clinical, commercial, and scientific experts crucial for healthcare product and service development. Lisa Suennen, Managing Partner of American Heart Association Ventures, now joins the MDisrupt board, bringing her vast experience in health innovation to steer MDisrupt's growth. This collaboration serves thousands of American Heart Association's professional members, allowing them to engage with the health tech industry and advance scientific expertise in the healthcare ecosystem.
The strategic alliance aims to foster innovative pathways for members to leverage their expertise in shaping future healthcare and technology solutions. "Healthcare experts are the vital drivers of scalable, science-based innovations," stated Ruby Gadelrab, CEO of MDisrupt. "Our collaboration with the Association provides unparalleled opportunities for its members to influence healthcare technology's future." This partnership embodies MDisrupt's mission to offer the healthcare and life sciences sectors access to top-tier clinicians and scientists, particularly in cardiovascular and brain health. By aligning with American Heart Association's goals, MDisrupt aids in distributing evidence-based, high-quality scientific insights across healthcare systems.
American Heart Association Ventures, dedicated to coordinating venture capital efforts that reflect the Association's mission, sees this investment as a step towards transforming scientific research and medical expertise into tangible healthcare benefits. "We are thrilled to support our members and the sector by aligning needs with expertise through MDisrupt," said Suennen. "Our collaboration helps elevate the Association's mission of ensuring longer, healthier lives by advancing healthcare breakthroughs globally." She emphasizes that trusted leadership is critical for driving effective health solutions.
Navigating healthcare innovation is challenging, with a high failure rate among startups. MDisrupt's marketplace addresses this issue by providing specialized guidance in clinical, regulatory, and commercialization areas. "Innovation often falters not from lack of creativity but from insufficient access to healthcare expertise," Gadelrab explained. "MDisrupt bridges this gap by connecting companies with precisely matched experts to navigate complex healthcare challenges." Offering more than 2,500 vetted professionals, MDisrupt ensures a tailored approach to engagement, from hourly consultations to full-time collaborations.
Founded by Ruby Gadelrab, a seasoned health tech executive with robust experience in commercializing healthcare innovations, MDisrupt has raised $6.6 million, including recent seed funding. Investors such as The Venture Collective and industry leaders endorse MDisrupt's vision of transforming healthcare innovation. As MDisrupt and American Heart Association Ventures join forces, they pave the way for transformative impacts on healthcare delivery and innovation, promising a robust ecosystem for future health solutions.